Advertisement
Advanced Search
We read with great interest the study by Brahmi et al [1] examining the effect of multiple-dose activated charcoal (MDAC) in carbamazepine (CBZ) poisoning. We applaud their prospective design, but we have questions about their group selection and half-life calculations.

Related Articles

Searching for related articles..

Advertisement

Linked Articles

Nozha Brahmi
DOI: http://dx.doi.org/10.1016/j.ajem.2006.12.003
The American Journal of Emergency Medicine, Vol. 25, Issue 4